According to the implementation plan of Good Manufacturing Practice for Drugs (2010 Revision) (hereinafter referred to as the newly revised GMP), the production of blood products, vaccines, injections and other sterile pharmaceutical products should meet the requirements of the newly revised GMP before December 31, 2013.

Information Source: http://www.sfda.gov.cn/WS01/CL0051/95648.html